Review decisions
Showing 460 results of 1549 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01071
Product Type: Drug
Control Number: 263913
DIN(s): 02534673
Manufacturer: Pharmaris Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-05-03
Decision / Authorization Date: 2023-01-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1705593803323
Product Type: Drug
Control Number: 234756
DIN(s): 02510162, 02510170
Manufacturer: Bayer Inc
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-12-24
Decision / Authorization Date: 2021-01-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1692037182503
Product Type: Drug
Control Number: 234666
DIN(s): 02245619, 02456915, 02512173
Manufacturer: Teva Canada Limited
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-12-23
Decision / Authorization Date: 2021-02-04
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1692291386055
Product Type: Drug
Control Number: 237401
DIN(s): 02145901, 02514435
Manufacturer: Sandoz Canada Incorporated
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-20
Decision / Authorization Date: 2021-04-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1694610519770
Product Type: Drug
Control Number: 241747
Manufacturer: Boehringer Ingelheim (Canada) Ltd Ltee
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-07-16
Decision / Authorization Date: 2021-06-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01052
Product Type: Drug
Control Number: 262408
Manufacturer: ModernaTX, Inc.
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2022-03-16
Decision / Authorization Date: 2023-01-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00737
Product Type: Drug
Control Number: 234655
DIN(s): 02503034
Manufacturer: Medunik Canada
Submission Type: New Drug Submission (New Active Substance) - Priority Review
Date Filed / Submission Date: 2019-12-20
Decision / Authorization Date: 2023-01-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01054
Product Type: Drug
Control Number: 265333
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-06-17
Decision / Authorization Date: 2023-01-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01055
Product Type: Drug
Control Number: 258973
DIN(s): 02534177, 02534185
Manufacturer: Celltrion Healthcare Co., Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-11-24
Decision / Authorization Date: 2023-01-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01053
Product Type: Drug
Control Number: 241617
Manufacturer: ALK-Abello A/S
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-07-10
Decision / Authorization Date: 2022-12-29